Ovarian Ablation for Premenopausal Breast Cancer: A Review of Treatment Considerations and the Impact of Premature Menopause
Highlights • Ovarian ablation (OA) is an important treatment for premenopausal breast cancer. • The 5-year survival benefit of OA as an adjuvant therapy is limited (1.4-3.6%). • OA causes premature menopause resulting in side effects and mortality risks. • Women contemplating OA require a comprehens...
Saved in:
Published in | Cancer treatment reviews Vol. 55; pp. 26 - 35 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier Ltd
01.04.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Highlights • Ovarian ablation (OA) is an important treatment for premenopausal breast cancer. • The 5-year survival benefit of OA as an adjuvant therapy is limited (1.4-3.6%). • OA causes premature menopause resulting in side effects and mortality risks. • Women contemplating OA require a comprehensive risk/benefit discussion. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
ISSN: | 0305-7372 1532-1967 |
DOI: | 10.1016/j.ctrv.2017.02.005 |